Debate Continues on Optimal Neoadjuvant Regimen in Resectable Pancreatic Cancer
April 2nd 2020
Michael A. Choti, MD, MBA, FACS, discusses the role of radiation therapy in neoadjuvant therapy for resectable pancreatic cancer, the many benefits of neoadjuvant therapy over up-front surgery, and minimally invasive surgical procedures that are coming to the forefront in this disease.